skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 38,335  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: subject: Oncology remove subject: Tumors remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Annual report of the committee on gynecologic oncology, the Japan Society of Obstetrics and Gynecology: Annual patients report for 2015 and annual treatment report for 2010
Material Type:
Article
Add to My Research

Annual report of the committee on gynecologic oncology, the Japan Society of Obstetrics and Gynecology: Annual patients report for 2015 and annual treatment report for 2010

The journal of obstetrics and gynaecology research, 2019-02, Vol.45 (2), p.289 [Peer Reviewed Journal]

2018 Japan Society of Obstetrics and Gynecology. ;EISSN: 1447-0756 ;DOI: 10.1111/jog.13863 ;PMID: 30426591

Digital Resources/Online E-Resources

2
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
Material Type:
Article
Add to My Research

Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer

The New England journal of medicine, 2023-06, Vol.388 (23), p.2159-2170 [Peer Reviewed Journal]

Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2302312 ;PMID: 36972022

Full text available

3
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
Material Type:
Article
Add to My Research

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer

The New England journal of medicine, 2023-06, Vol.388 (23), p.2145-2158 [Peer Reviewed Journal]

Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2216334 ;PMID: 36972026

Full text available

4
ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors
Material Type:
Article
Add to My Research

ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors

International journal of gynecological cancer, 2021-07, Vol.31 (7), p.961-982 [Peer Reviewed Journal]

IGCS and ESGO 2021. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. ;2021 IGCS and ESGO 2021. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, an indication of whether changes were made, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;IGCS and ESGO 2021. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. 2021 ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2021-002565 ;PMID: 34112736

Full text available

5
Role of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node low-volume metastasis in early-stage cervical cancer
Material Type:
Article
Add to My Research

Role of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node low-volume metastasis in early-stage cervical cancer

International journal of gynecological cancer, 2020-03, Vol.30 (3), p.364-371 [Peer Reviewed Journal]

IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology. ;2020 IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2019-000939 ;PMID: 31980488

Full text available

6
Revised 2018 International Federation of Gynecology and Obstetrics (FIGO) cervical cancer staging: A review of gaps and questions that remain
Material Type:
Article
Add to My Research

Revised 2018 International Federation of Gynecology and Obstetrics (FIGO) cervical cancer staging: A review of gaps and questions that remain

International journal of gynecological cancer, 2020-06, Vol.30 (6), p.873-878 [Peer Reviewed Journal]

IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology. ;2020 IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2020-001257 ;PMID: 32241876

Full text available

7
Sentinel lymph node biopsy alone in the management of early cervical carcinoma
Material Type:
Article
Add to My Research

Sentinel lymph node biopsy alone in the management of early cervical carcinoma

International journal of gynecological cancer, 2022-01, Vol.32 (1), p.15-20 [Peer Reviewed Journal]

IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2019-001082 ;PMID: 32546643

Full text available

8
Human papillomavirus-independent cervical cancer
Material Type:
Article
Add to My Research

Human papillomavirus-independent cervical cancer

International journal of gynecological cancer, 2022-01, Vol.32 (1), p.1-7 [Peer Reviewed Journal]

IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2021-003014 ;PMID: 34725203

Full text available

9
ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
Material Type:
Article
Add to My Research

ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

International journal of gynecological cancer, 2019-05, Vol.29 (4), p.728-760 [Peer Reviewed Journal]

The Authors 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 The Authors 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;ISSN: 1525-1438 ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2019-000308 ;PMID: 31048403

Full text available

10
CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III, randomized, double-blind, multicenter study
Material Type:
Article
Add to My Research

CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III, randomized, double-blind, multicenter study

International journal of gynecological cancer, 2020-07, Vol.30 (7), p.1065-1070 [Peer Reviewed Journal]

IGCS and ESGO 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. ;2020 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology. ;2020 IGCS and ESGO 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, an indication of whether changes were made, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;IGCS and ESGO 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. 2020 ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2019-001135 ;PMID: 32447296

Full text available

11
It is time to implement molecular classification in endometrial cancer
Material Type:
Article
Add to My Research

It is time to implement molecular classification in endometrial cancer

Archives of gynecology and obstetrics, 2024-03, Vol.309 (3), p.745 [Peer Reviewed Journal]

2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. ;EISSN: 1432-0711 ;DOI: 10.1007/s00404-023-07128-z ;PMID: 37410149

Digital Resources/Online E-Resources

12
FIGO 2023 endometrial cancer staging: too much, too soon?
Material Type:
Article
Add to My Research

FIGO 2023 endometrial cancer staging: too much, too soon?

International journal of gynecological cancer, 2024-01, p.ijgc-2023-004981 [Peer Reviewed Journal]

2023 IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2023-004981

Digital Resources/Online E-Resources

13
SENTICOL III: an international validation study of sentinel node biopsy in early cervical cancer. A GINECO, ENGOT, GCIG and multicenter study
Material Type:
Article
Add to My Research

SENTICOL III: an international validation study of sentinel node biopsy in early cervical cancer. A GINECO, ENGOT, GCIG and multicenter study

International journal of gynecological cancer, 2019-05, Vol.29 (4), p.829-834 [Peer Reviewed Journal]

2019 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology. ;IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2019-000332 ;PMID: 30898938

Full text available

14
Management of ovarian masses in pregnancy: patient selection for interventional treatment
Material Type:
Article
Add to My Research

Management of ovarian masses in pregnancy: patient selection for interventional treatment

International journal of gynecological cancer, 2021-06, Vol.31 (6), p.899-906 [Peer Reviewed Journal]

IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2020-001996 ;PMID: 33172924

Full text available

15
Immunohistochemical analysis of the epithelial to mesenchymal transition in uterine carcinosarcoma
Material Type:
Article
Add to My Research

Immunohistochemical analysis of the epithelial to mesenchymal transition in uterine carcinosarcoma

International journal of gynecological cancer, 2019-02, Vol.29 (2), p.277-281 [Peer Reviewed Journal]

IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology. ;2019 IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2018-000038 ;PMID: 30636710

Full text available

16
Complications of HIPEC for ovarian cancer surgery: evaluation over two time periods
Material Type:
Article
Add to My Research

Complications of HIPEC for ovarian cancer surgery: evaluation over two time periods

International journal of gynecological cancer, 2024-01, p.ijgc-2023-004658 [Peer Reviewed Journal]

2023 IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2023-004658

Digital Resources/Online E-Resources

17
Circulating Inflammation Markers and Risk of Epithelial Ovarian Cancer
Material Type:
Article
Add to My Research

Circulating Inflammation Markers and Risk of Epithelial Ovarian Cancer

Cancer epidemiology, biomarkers & prevention, 2011-05, Vol.20 (5), p.799-810 [Peer Reviewed Journal]

2015 INIST-CNRS ;2011 AACR. ;ISSN: 1055-9965 ;ISSN: 1538-7755 ;EISSN: 1538-7755 ;DOI: 10.1158/1055-9965.EPI-10-1180 ;PMID: 21467242 ;CODEN: CEBPE4

Full text available

18
Survival after minimally invasive surgery in early cervical cancer: is the intra-uterine manipulator to blame?
Material Type:
Article
Add to My Research

Survival after minimally invasive surgery in early cervical cancer: is the intra-uterine manipulator to blame?

International journal of gynecological cancer, 2020-12, Vol.30 (12), p.1864-1870 [Peer Reviewed Journal]

IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2020-001816 ;PMID: 33037109

Full text available

19
Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial
Material Type:
Article
Add to My Research

Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial

The lancet oncology, 2016, Vol.17 (1), p.78-89 [Peer Reviewed Journal]

Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 1, 2016 ;ISSN: 1470-2045 ;ISSN: 1474-5488 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(15)00366-6 ;PMID: 26590673

Full text available

20
The role of factor XIII in surgery for advanced stage of epithelial ovarian cancer
Material Type:
Article
Add to My Research

The role of factor XIII in surgery for advanced stage of epithelial ovarian cancer

Archives of gynecology and obstetrics, 2022-05, Vol.305 (5), p.1311-1318 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 ;2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. ;The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021. ;ISSN: 1432-0711 ;ISSN: 0932-0067 ;EISSN: 1432-0711 ;DOI: 10.1007/s00404-021-06308-z ;PMID: 34724570

Full text available

Results 1 - 20 of 38,335  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1989  (2,149)
  2. 1989 To 1997  (6,648)
  3. 1998 To 2006  (12,975)
  4. 2007 To 2016  (15,209)
  5. After 2016  (1,388)
  6. More options open sub menu

Language 

  1. English  (38,333)
  2. Japanese  (7,724)
  3. German  (16)
  4. French  (4)
  5. Turkish  (2)
  6. Chinese  (1)
  7. Polish  (1)
  8. Norwegian  (1)
  9. More options open sub menu

Searching Remote Databases, Please Wait